
摘要号:402O
英文标题:Perioperative enfortumab vedotin plus pembrolizumab (EV + pembro) versus neoadjuvant cisplatin-based chemotherapy in participants (pts) with muscle-invasive bladder cancer (MIBC) in the Asia subset of KEYNOTE-B15
中文标题:KEYNOTE-B15 研究亚洲亚组:肌层浸润性
讲者:
类型:Proffered Paper session
摘要号:244RO
研究名称(英文):Efficacy and safety of Trastuzumab Brengitecan (T-Bren) in patients with HER2-expressing locally advanced or metastatic urothelial carcinoma: Results from a phase Ib/II study
研究名称(中文):Trastuzumab Brengitecan(T-Bren)用于 HER2 表达局部晚期或转移性尿路上皮癌:一项 Ib/II 期研究结果
讲者:
类型:Rapid Oral session
摘要号:404RO
英文标题:NEOBLAST Study Update: A Prospective, Single-Arm, Multi-Center, Pilot Study of Neoadjuvant Adebrelimab plus Etoposide and Cisplatin in Patients with Neuroendocrine Bladder Carcinoma
中文标题:NEOBLAST研究更新:
讲者:
类型:Rapid Oral session
摘要号:405RO
英文标题:Induction chemotherapy followed by toripalimab, disitamab vedotin, and radiotherapy for bladder preservation in HER2-positive muscle-invasive bladder cancer (MIBC): An open-label, single-arm study
中文标题:HER2 阳性肌层浸润性膀胱癌(MIBC):诱导化疗序贯
讲者:刘博 华中科技大学同济医学院附属同济医院
类型:Rapid Oral session
摘要号:406RO
英文标题:SC-101, a Nectin-4-targeting peptide–drug conjugate, in patients with advanced urothelial carcinoma: Updated results from a phase 1 dose-escalation and dose-expansion study
中文标题:SC-101(一种靶向Nectin-4的多肽偶联药物)在晚期尿路上皮癌患者中的应用:一项1期剂量递增与剂量扩展研究的最新结果
讲者:
类型:Rapid Oral session
摘要号:407RO
英文标题:Prognostic Implications of ypTNM Staging After Neoadjuvant Systemic Therapy in Non-metastatic Clear Cell Renal Cell Carcinoma: A Propensity Score–Matched Analysis
中文标题:非转移性透明细胞
讲者:宋佳龙 中国人民解放军总医院
类型:Rapid Oral session
摘要号:408RO
英文标题:Circulating metabolomics Analysis in a Prospective Co-clinical Trial Identifies succinate-modifying metabolites as Response Biomarkers for Combination Immunotherapy in Advanced Fumarate hydratase Deficient Renal Cell Carcinoma
中文标题:一项前瞻性联合临床试验中的循环代谢组学分析发现,琥珀酸修饰相关代谢物可作为晚期延胡索酸水合酶缺陷型肾细胞癌联合免疫治疗的疗效生物标志物
讲者:徐云泽 上海交通大学医学院附属仁济医院
类型:Rapid Oral session
摘要号:740RO
英文标题:HRS-1738, an 18F‑labeled prostate-specific membrane antigen (PSMA)‑targeted PET tracer, for imaging of prostate cancer (PCa): a multicenter phase I/II study
中文标题:HRS-1738(靶向 PSMA 的 18F 标记 PET 示踪剂)用于
讲者:柳晨 北京大学肿瘤医院
类型:Rapid Oral session
摘要号:741RO
英文标题:Comparative Biomarker Profiling in the First-in-Human (FIH) Trial of Pasritamig in Visceral and Nonvisceral Metastatic Castration-Resistant Prostate Cancer (mCRPC)
中文标题:Pasritamig 首次人体(FIH)试验:内脏转移与非内脏转移转移性去势抵抗性前列腺癌(mCRPC)的生物标志物谱对比分析
讲者:
类型:Rapid Oral session
医脉通是专业的在线医生平台,“感知世界医学
本平台旨在为医疗卫生专业人士传递更多医学信息。本平台发布的内容,不能以任何方式取代专业的医疗指导,也不应被视为诊疗建议。如该等信息被用于了解医学信息以外的目的,本平台不承担相关责任。本平台对发布的内容,并不代表同意其描述和观点。若涉及版权问题,烦请权利人与我们联系,我们将尽快处理。